REPACE: The Revolutionary Scientific Workout Solution

NEW YORK, NY, October 11, 2021 /24-7PressRelease/ — The medical device manufacturer OBELAB has announced the launch of its personal, customizable workout solution fitness device ‘REPACE.’ ‘REAPCE’ is a smart device that does not require its users to draw blood to check their muscular oxygen saturation levels. It also provides personalized workout solutions.

The pre-existing fitness devices were only able to provide primary health status, based on biometric data such as heart rates, calories burnt, etc. ‘REPACE’ measures the individual users’ physical abilities using functional near-infrared spectroscopy (fNIRS). This method is its leading technology. To receive their workout solution, its users would not have to draw blood to check their muscular oxygen saturation levels.

Users must attach the device to its straps, put it on to the user’s thighs, and pair REPACE with its application to get their LT TEST results and personalized workout done. Based on the LT TEST and the user’s goals (weight loss, physical fitness, exercise abilities, etc.) REPACE will provide every individual of their personalized workout solutions. To motivate its users, REPACE also provides a ranking system and hands out trophies and medals. Apart from the ranks, it also provides its own community for users to share their workout records on Facebook with their friends, thus preventing runners/users from wearing out on its app.

REPACE supports non-professional users in upgrading their physical fitness based on its prolonged development period of 8 years with its oxygen saturation tracker built initially for professional athletes. The algorithm used in this technology enables the public to plan, edit, and carry out their personalized workouts and upgrade their physical activities based on scientific data.

‘REPACE’ has announced its official launch this coming October on the global crowdfunding platform, KICKSTARTER. More information can be found on its official Kickstarter campaign page.

For the original version of this press release, please visit here